Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway
D Xu, H Zhao, H Gao, H Zhao, D Liu, J Li - Molecular pain, 2018 - journals.sagepub.com
Background Neuropathic pain is observed in patients as chemotherapeutic oxaliplatin is
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway.
D Xu, H Zhao, H Gao, H Zhao, D Liu, J Li - Molecular Pain, 2018 - search.ebscohost.com
Background: Neuropathic pain is observed in patients as chemotherapeutic oxaliplatin is
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway.
D Xu, H Zhao, H Gao, D Liu, J Li - Molecular Pain, 2018 - europepmc.org
Background Neuropathic pain is observed in patients as chemotherapeutic oxaliplatin is
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway
D Xu, H Zhao, H Gao, H Zhao, D Liu, J Li - Molecular pain, 2018 - pubmed.ncbi.nlm.nih.gov
Background Neuropathic pain is observed in patients as chemotherapeutic oxaliplatin is
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
[HTML][HTML] Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway
D Xu, H Zhao, H Gao, H Zhao, D Liu, J Li - Molecular Pain, 2018 - ncbi.nlm.nih.gov
Background Neuropathic pain is observed in patients as chemotherapeutic oxaliplatin is
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
[引用][C] Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway
D Xu - Mol Pain, 2018 - cir.nii.ac.jp
Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic
oxaliplatin via central GABAergic pathway | CiNii Research CiNii 国立情報学研究所 学術 …
oxaliplatin via central GABAergic pathway | CiNii Research CiNii 国立情報学研究所 学術 …
[引用][C] Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway
D Xu, H Zhao, H Gao, H Zhao, D Liu, J Li - Molecular Pain, 2018 - cir.nii.ac.jp
Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic
oxaliplatin via central GABAergic pathway | CiNii Research CiNii 国立情報学研究所 学術情報 …
oxaliplatin via central GABAergic pathway | CiNii Research CiNii 国立情報学研究所 学術情報 …
Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway.
D Xu, H Zhao, H Gao, D Liu, J Li - Molecular Pain, 2018 - europepmc.org
Background Neuropathic pain is observed in patients as chemotherapeutic oxaliplatin is
used to treat metastatic digestive tumors; however, the mechanisms responsible for …
used to treat metastatic digestive tumors; however, the mechanisms responsible for …